Your provider assesses your current use of spironolactone, other diuretics, blood pressure medications, and any kidney or heart conditions before you start treatment
But thats just the starting point
analyzed commercial claims data (see Figure 2) and found that persistent GLP-1 users had $14K-$15K (about 14%) lower average annual total cost of care in the first one to two years of use compared with chronically obese patients who never tried GLP-1s
UCHealth Anschutz Health & Wellness Center, Aurora Picture a clinic where dietitians, surgeons, exercise physiologists, and psychologists sit a hallway apart
Instead, GLP-3 refers to investigational triple-agonist medications that activate three different hormone receptors simultaneously: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and GCG (glucagon)